In an interaction with India Pharma Outlook, Deepak Ghagare, Associate Director SBS, Spectrum Pharmatech shares insights on India’s evolving HPAPI manufacturing landscape, emphasizing advanced containment strategies and regulatory alignment.

A few months ago, I came across the story of an Indian pharmaceutical exporter whose shipment to the US market was rejected at the port. This rejection had nothing to do with product formulation or its manufacturing and safety process...

In an exclusive interaction with Thiruamuthan, Correspondent at India Pharma Outlook, Ashutosh K. Sinha, Chief Quality Officer at Neuland Laboratories Limited, shares his perspectives on how Indian CDMOs are strengthening their global competitiveness

In an interaction with Thiruamuthan, Correspondent at India Pharma Outlook, Vikram Aditya Sehgal, Director – Finance, Centrient India, discusses India’s PLI-backed API projects are strengthening domestic manufacturing and reducing import dependence,

As demand grows for microbiome-safe and skin-type-specific hygiene products, how are Indian brands rethinking personalization across formulation, packaging, and user engagement strategies

Arushi Jain, a corporate growth strategist in the pharmaceutical sector, brings over a decade of cross-functional experience. She specializes in operational excellence, risk advisory, and scaling healthcare ventures. With expertise spanning internal